Department of Neurology and Neurological Sciences, Stanford University, Stanford, CA, USA.
Department of Neurology, Washington University School of Medicine, St Louis, MO, USA.
Nature. 2021 Jun;594(7862):277-282. doi: 10.1038/s41586-021-03580-6. Epub 2021 May 26.
Neurons have recently emerged as essential cellular constituents of the tumour microenvironment, and their activity has been shown to increase the growth of a diverse number of solid tumours. Although the role of neurons in tumour progression has previously been demonstrated, the importance of neuronal activity to tumour initiation is less clear-particularly in the setting of cancer predisposition syndromes. Fifteen per cent of individuals with the neurofibromatosis 1 (NF1) cancer predisposition syndrome (in which tumours arise in close association with nerves) develop low-grade neoplasms of the optic pathway (known as optic pathway gliomas (OPGs)) during early childhood, raising the possibility that postnatal light-induced activity of the optic nerve drives tumour initiation. Here we use an authenticated mouse model of OPG driven by mutations in the neurofibromatosis 1 tumour suppressor gene (Nf1) to demonstrate that stimulation of optic nerve activity increases optic glioma growth, and that decreasing visual experience via light deprivation prevents tumour formation and maintenance. We show that the initiation of Nf1-driven OPGs (Nf1-OPGs) depends on visual experience during a developmental period in which Nf1-mutant mice are susceptible to tumorigenesis. Germline Nf1 mutation in retinal neurons results in aberrantly increased shedding of neuroligin 3 (NLGN3) within the optic nerve in response to retinal neuronal activity. Moreover, genetic Nlgn3 loss or pharmacological inhibition of NLGN3 shedding blocks the formation and progression of Nf1-OPGs. Collectively, our studies establish an obligate role for neuronal activity in the development of some types of brain tumours, elucidate a therapeutic strategy to reduce OPG incidence or mitigate tumour progression, and underscore the role of Nf1mutation-mediated dysregulation of neuronal signalling pathways in mouse models of the NF1 cancer predisposition syndrome.
神经元最近被认为是肿瘤微环境中必不可少的细胞成分,其活性已被证明会增加多种实体瘤的生长。尽管神经元在肿瘤进展中的作用以前已经得到证实,但神经元活性对肿瘤起始的重要性尚不清楚——特别是在癌症易感性综合征的背景下。15%患有神经纤维瘤病 1 型 (NF1) 癌症易感性综合征的个体(其中肿瘤与神经密切相关)在幼儿期会发展出视神经通路的低级别肿瘤(称为视神经胶质瘤 (OPG)),这增加了视神经出生后光诱导活动驱动肿瘤起始的可能性。在这里,我们使用一种经过验证的 Nf1 基因突变驱动的 OPG 小鼠模型(Nf1 肿瘤抑制基因)来证明视神经活动的刺激会增加视神经胶质瘤的生长,并且通过剥夺光减少视觉体验可以防止肿瘤形成和维持。我们表明,Nf1 驱动的 OPG(Nf1-OPG)的起始取决于在 Nf1 突变小鼠易发生肿瘤形成的发育期间的视觉体验。视网膜神经元中的种系 Nf1 突变导致视神经中神经连接蛋白 3 (NLGN3) 的异常脱落增加,这是对视网膜神经元活性的反应。此外,遗传缺失 Nlgn3 或药理学抑制 NLGN3 脱落可阻止 Nf1-OPG 的形成和进展。总的来说,我们的研究确立了神经元活性在某些类型脑肿瘤发展中的必需作用,阐明了一种减少 OPG 发生率或减轻肿瘤进展的治疗策略,并强调了 Nf1 突变介导的神经元信号通路失调在 NF1 癌症易感性综合征小鼠模型中的作用。